Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus

Behavioural Brain Research

Volumn 88, Issue 1, 1997, Pages 35-41

  Ruob, C ^a   Elsner, J ^a   Weiner, I ^b   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amphetamine; Dopamine; Haloperidol; Latent inhibition; Rat; Schizophrenia; Stimulus

Indexed keywords

AMPHETAMINE DERIVATIVE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CONDITIONING; CONFERENCE PAPER; CONTROLLED STUDY; EMOTION; LATENT INHIBITION; LICKING; MALE; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; RAT; REINFORCEMENT; SCHIZOPHRENIA; VISUAL STIMULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; DARKNESS; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; HALOPERIDOL; MALE; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); STARTLE REACTION;

EID: 0030828127     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)02305-X     Document Type: Conference Paper

References (31)

1. Baruch, I., Hemsley D. and Gray J.A., Differential performance of acute and chronic schizophrenics in a latent inhibition task, J Nerv. Ment. Dis., 176 (1988) 598-606.
2. Christison, G.W., Atwater G.E., Dunn L.A. and Kilts C.D., Haloperidol enhancement of latent inhibition: Relation to therapeutic action?, Biol. Psychiatry, 23 (1988) 746-749.
3. De la Casa, L.G., Ruiz, G. and Lubow, R.E., Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: Implications for schizophrenia, Biol. Psychiatry, 33 (1993) 707-711.
4. Dunn, L.A., Atwater G.E. and Kilts C.D., Effects of antipsychotic drugs on latent inhibition-sensitivity and specificity of an animal behavioral model of clinical drug action, Psychopharmacology, 112 (1993) 315-323.
5. Feldon, J. and Weiner, I., The latent inhibition model of schizophrenic attention disorder: Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli, Biol. Psychiatry, 29 (1991) 635-646.
6. Gray, J.A., Feldon, J., Rawlins, J.N.P., Hemsley, D.R. and Smith, A.D., The neuropsychology of schizophrenia, Behav. Brain Sci., 14 (1991) 1-84.
7. Gray, N.S., Hemsley, D.R. and Gray, J.A., Abolition of latent inhibition in acute, but not chronic, schizophrenics, Neurol. Psychiatry Brain Res., 1 (1992a) 83-89.
8. [7a] Gray, J.A., Moran, P.M., Grigoryan, G., Peters, S.L., Young, A.M.J. and Joseph, M.H., Latent inhibition: The nucleus accumbens connection revisited, Behav. Brain Res., in press.
9. Gray, N.S., Pickering, A.D., Hemsley, D.R., Dawling, S. and Gray, J.A., Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man, Psychopharmacology, 107 (1992b) 425-430.
10. Gray, N.S., Pilowsky, L.S., Gray, J.A. and Kerwin, R.W., Latent inhibition in drug naive schizophrenics: Relationship to duration of illness and dopamine D2 binding using SPET, Schizophr. Res., 17 (1995) 95-107.
11. Killcross, A.S., Dickinson, A. and Robbins, T.W., Amphetamine-induced disruptions of latent inhibition are reinforcer mediated-implications for animal models of schizophrenic attentional dysfunction, Psychopharmacology, 115 (1994a) 185-195.
12. Killcross, A.S., Dickinson, A. and Robbins, T.W., Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms-evidence for dopamine-reinforcer interactions, Psychopharmacology, 115 (1994b) 196-205.
13. Killcross, A.S. and Robbins, T.W., Differential effects of intraaccumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm, Psychopharmacology, 110 (1993) 479-489.
14. Lubow, R.E., Latent inhibition, Psychol. Bull., 79 (1973) 398-407.
15. Lubow, R.E., Latent Inhibition and Conditioned Attention Theory, Cambridge University Press, New York, 1989.
16. Lubow, R.E. and Gewirtz, J.C., Latent inhibition in humans: Data, theory and implications for schizophrenia, Psychol. Bull., 117 (1995) 87-103.
17. Lubow, R.E., Weiner, I. and Schnur P., Conditioned attention theory. In: G.H. Bower (Ed.), The Psychology of Learning and Motivation, Vol. 15., Academic Press, New York, 1981, pp. 1-49.
18. Peters, S.L. and Joseph, M.H., Haloperidol potentiation of latent inhibition in rats: Evidence for a critical role at conditioning rather than pre-exposure, Behav. Pharmacol., 4 (1993) 183-186.
19. [17a] Rochford, J., Sen, A.P. and Quirion, R., Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat, J. Pharmacol. exp. Ther., 277 (1996) 1267-1275.
20. Solomon, P.R., Crider, A., Winkelman, J.W., Turi, A., Kamer, R.M. and Kaplan, L.J., Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder, Biol. Psychiatry, 16 (1981) 519-537.
21. Solomon, P.R. and Staton, D.M., Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus, Biol. Psychiatry, 17 (1982) 743-756.
22. Warburton, E.C., Joseph, M.H., Feldon, J., Weiner, I. and Gray, J.A., Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperdiol and ondansetron-implications for a possible antipsychotic action of ondansetron, Psychopharmacology, 114 (1994) 657-664.
23. Weiner, I., Neural substrates of latent inhibition: The switching model, Psychol. Bull, 108 (1990) 442-461.
24. Weiner, I. and Feldon, J., Facilitation of latent inhibition by haloperidol, Psychopharmacology, 91 (1987) 248-253.
25. Weiner, I., Izraeli-Telerant, A. and Feldon J., Latent inhibition is not affected by acute or chronic administration of 6 mg/kg DL-amphetamine, Psychopharmacology, 91 (1987) 345-351.
26. Weiner, I., Lubow, R.E. and Feldon, J., Chronic amphetamine and latent inhibition, Behav. Brain Res., 2 (1981) 285-286.
27. Weiner, I., Lubow, R.E. and Feldon, J., Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats, Psychopharmacology, 83 (1984) 194-199.
28. Weiner, I., Lubow, R.E. and Feldon, J., Disruption of latent inhibition by acute administration of low doses of amphetamine, Pharmacol. Biochem. Behav., 30 (1988) 871-878.
29. Weiner, I., Shadach, E., Barkai, R. and Feldon, J., Haloperidol and clozapine induced enhancement of latent inhibition with extended conditioning: Implications for the mechanism of action of neuroleptic drugs, Neuropsychopharmacology, 16 (1997) 42-50.
30. Weiner, I., Shadach, E., Tarrasch, R., Kidron, R. and Feldon, J., The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic clozapine, Biol. Psychiatry, 40 (1996) 834-843.
31. Weiner, I., Tarrasch, R., Bernasconi, E., Broersen, L.M., Rüttimann, T.C., and Feldon, J., Amphetamine-induced disruption of latent inhibition is not reinforcer mediated, Pharmacol. Biochem. Behav., in press.